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Endoplasmic Reticulum Stress and Pancreatic Cancer
Review / Derleme
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Özet
Endoplazmik retikulum (ER) stres, farklı uyaranlar sonucu gelişen önemli hücre-
sel bir olaydır. ER strese farklı yanıt türleri vardır. Bunlardan biri evrimsel olarak 
korunmuş katlanmamış protein cevabıdır (UPR). UPR’nin moleküllerin sonraki 
aktivasyonu için üç sensörü vardır. Bu sensörler inozitol gerektiren enzim 1 (IRE1), 
aktive edici transkripsiyon faktörü 6 (ATF6) ve protein kinaz RNA (PKR)-benzeri 
ER kinaz (PERK). ER stresin olmadığı durumlarda bu sensörler inaktif durumda 
tutulurlar. Ancak ER stres durumunda aktif hale gelirler ve yolaktaki alt basa-
mak hedeflerini indüklerler. ER stresin sonucunda hücre ya canlı kalabilir ya da 
ölebilir. Pek çok çalışmada ER stresin farklı tipte hastalıklarla; örneğin diyabet, 
Alzheimer hastalığı, prion hastalığı, kanser vb; bağlantılı olduğu gösterilmiştir. 
Bir kanser türü olarak pankreas kanserinin de ER stres ile ilişkili olduğu gösteril-
miştir. Pankreas kanseri geç tanısı ile birlikte düşük tedavi edilebilme potansiye-
line sahiptir. Pankreas kanserinin ER stres ile olan ilişkisi yeni bir tedavi yaklaşımı 
olarak görülmektedir. Bu derlemenin amacı ER stresin tetiklediği mekanizmalar 
üzerine ve patogenezinde etkili olduğu hastalıklardan biri olan pankreas kanseri 
ile olan ilişkisine genel bir bakış yapmaktır.
ANAHTAR KELİMELER: Endoplazmik retikulum, pankreas kanseri, stres
Abstract
Endoplasmic reticulum (ER) stress, which results from different stimuli, is an im-
portant cellular event. There are different types of response to ER stress. One 
of them is evolutionarily conserved unfolded protein response (UPR). UPR has 
three sensors for further activation of molecules. These sensors are inositol-re-
quiring enzyme 1 (IRE1), activated transcription factor 6 (ATF6), and ER-resident 
protein kinase RNA (PKR)-like ER kinase (PERK). In the absence of ER stress, these 
sensors are maintained in an inactive state. However, under ER stress conditions, 
they became activated and induce the downstream targets. As a consequence 
of ER stress, the cell may stay alive or became dead. Several studies have shown 
that ER stress is associated with different types of diseases such as diabetes mel-
litus, Alzheimer’s disease, prion disease, and cancer. As a cancer type, it has been 
shown that pancreatic cancer is also associated with ER stress. Pancreatic cancer 
has a low cure potential with its late diagnosis. Its association with ER stress is 
seen as a new therapeutic approach. The aim of this is review is to provide an 
overview of the mechanisms of ER stress and its relationship with pancreatic 
cancer, one of the diseases in which ER stress affects pathogenesis.
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1. Endoplasmic Reticulum (ER) Stress
The ER is an important organelle composed of cisternae in eukaryotic cells. It is the basic component of the secretory pathway and has 
a role in protein, lipid, and steroid synthesis; proper protein folding and trafficking; post-translational modifications (PTMs); and calcium 
homoeostasis (1). Because of its important role in different processes, its functions are under tight control (2).
Stress in ER, which may result from conditions such as hypoxia, changes in Ca2+ concentrations, ischemia, viral infections, inflammation, 
and errors in PTM, causes accumulation of misfolded or unfolded proteins in the ER. These situations generate a stress condition for this 
organelle, named as ER stress (3).
Cells use some mechanisms to deal with ER stress. One of them is unfolded protein response (UPR) and the other one is ER-associated 
degradation (ERAD) to provide ER homeostasis back (4). As a result of UPR activation, protein synthesis is arrested and expression of 
chaperons and ERAD processes are activated (1). However, if these events are not enough to cope with ER stress and there is prolonged 
ER stress, then the cell chooses programmed cell death mechanisms (5, 6).
2. UPR Pathways
Unfolded protein response is an evolutionarily conserved adaptive signaling mechanism that contains three ER stress sensors: inosi-
tol-requiring enzyme 1 (IRE1), activated transcription factor 6 (ATF6), and ER-resident protein kinase RNA (PKR)-like ER kinase (PERK) (7). 
In the absence of stress, UPR is maintained in an inactive state. This is achieved by binding of BiP/GRP78 (glucose-regulated protein) to 
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these three ER stress sensors (8). However, in an ER stress condition, 
GRP 78 dissociates from IRE1, PERK, and ATF-6, and results in the acti-
vation of stress response (1).
IRE1 is a type 1 ER transmembrane kinase and has two isoforms, 
IRE1α and IRE1β (9). After induction of UPR, IRE1 dimerizes and au-
tophosphorylates to become active (10). Activated IRE1 ensures the 
splicing of X-box-binding protein 1 (XBP1) mRNA, which results in the 
expression of transcription factors and upregulates UPR target genes 
responsible for protein folding, such as chaperons and protein disul-
fide isomerase (PDI) (11). PERK is another type 1 ER transmembrane 
kinase similar to IRE1. In an ER stress condition, PERK dimerizes and 
autophosphorylates itself and becomes activated. This process is fol-
lowed by phosphorylation of eukaryotic initiation factor 2 (eIF2α) on 
its Ser51 resides in α subunit (12). This phosphorylation attenuates 
the global mRNA translation through inhibition of ribosomal initia-
tion complex formation. Expressions of some specific genes carry on 
such as activating transcription factor 4 (ATF4) (13). ATF4 is an im-
portant transcription factor for the regulation of several UPR target 
genes such as C/EBP homologous protein (CHOP), which has a role 
in ER stress-mediated apoptosis (14). A third regulator of UPR is ATF6, 
which is a type II ER transmembrane protein, a basic leucine zipper 
transcription factor, and has two isoforms: ATF6α and ATF6β (15). 
Upon ER stress, ATF6α transits to the Golgi and becomes activated 
after being subjected to proteolytic cleavage (1). Thereafter, the ac-
tivated ATF6 translocates to the nucleus and activates downstream 
UPR response genes (16, 17).
These processes ensure the adaptation and provide homeostasis 
back. However, in case of high levels of chronic and prolonged ER 
stress that the UPR response cannot cope with, programmed cell 
death, i.e., apoptosis and autophagy, occurs (5). 
3. ER Stress and Cell Death Mechanisms
a. ER stress and apoptosis
Apoptosis is induced through downstream effectors of ER stress sen-
sors. ER stress can induce both intrinsic and extrinsic apoptotic path-
ways (18). Similar to the mitochondria, the ER contains components 
of both proapoptotic (caspase-12, p28Bap31, and GADD153) and 
antiapoptotic molecules [GRP78, calreticulin, PDI, oxygen-regulated 
protein (ORP-150), and defender against apoptotic death-1 (DAD1)] 
(19-24). 
CHOP, also known as growth arrest and DNA damage-inducible protein 
153 (GADD 153), is the main component of the apoptosis in response 
to ER stress (25). PERK and ATF6 pathways activates CHOP, which in 
turn activates the expression of pro-apoptotic factors such as Tribbles 
3, GADD34, and death receptor 5 (DR5). The other components of the 
ER stress-mediated apoptotic pathway are Bcl-2 family members (Bak/
Bax), caspase-12, and c-jun NH2 terminal kinase (JNK) (26).
There are some pathways that play a role in the induction of ER 
stress-mediated apoptosis. One of them starts with homodimeriza-
tion and autophosphorylation of PERK. After PERK activation, it 
phosphorylates eIF2α, which blocks the global gene expression and 
induces selective ATF4 gene expression. Then, this transcription fac-
tor induces the expression of CHOP (27), which induces the expres-
sion of many proapoptotic factors including DR5, Tribbles homolog 
3 (TRB3), carbonic anhydrase VI (CAVI), and proapoptotic Bcl-2 family 
proteins (28). It has been shown that cells lacking CHOP are protected 
from ER stress-induced apoptosis (29). Under non-stressed conditions, 
CHOP expression is maintained at a very low level (17). Growth arrest 
and DNA damage-inducible protein 34 (GADD34) and an ER oxidase, 
ERO1α, are activated by CHOP, which leads to apoptosis through in-
creasing the protein synthesis and oxidation in the ER of stressed cells 
(28). It has been shown that CHOP can also be activated by ATF6 (17).
Another pathway starts with the activation of IRE1α by homodi-
merization and autophosphorylation. After activation, IRE1 α inter-
acts with TNF receptor-associated factor-2 (TRAF 2). TRAF2 activates 
apoptosis signaling kinase 1 (ASK1) and they form a complex. This 
complex subsequently activates the JNK-mediated apoptotic path-
way. JNK activation results in the phosphorylation of proapoptotic 
Bcl-2 family proteins. In addition, it inactivates antiapoptotic Bcl-2 
family proteins (30). 
Besides these pathways, ER stress can be induced by the Bcl-2 fam-
ily members Bax and Bak. Their localization and oligomerization at 
the ER promotes calcium release from the ER to the cytosol (31). With 
the increase in Ca2+ concentration in the cytoplasm, the calcium-de-
pendent cysteine protease m-Calpain becomes activated, resulting 
in the cleavage and activation of the ER-resident procaspase-12 
(32, 33). Active caspase-12 leads to the activation of the caspase cas-
cade (28). In addition, increase in cytosolic calcium concentration in-
creases the calcium influx into the mitochondrial matrix, which can 
change the polarization profile of the inner membrane and result in 
the transition of the outer membrane permeability pore. This event 
causes the release of cytochrome c and activation of apoptosomes, 
leading to apoptosis (28, 34).
Thus, in general, it can be considered that UPR is double-faced mech-
anism as it can induce cell survival by induction of GRP78 and cell 
death through induction of CHOP (35).
b. ER stress and autophagy
There are three different types of autophagy: macroautophagy, mi-
croautophagy, and chaperon-mediated autophagy (36). Macroau-
tophagy is a lysosomal pathway involved in the turnover of cellular 
macromolecules and organelles. It consists of some basic steps, such 
as induction, formation of isolation membrane by nucleation, elon-
gation, docking, fusion with lysosomes, and breakdown (37). It has 
been shown that macroautophagy also has a role in dealing with ER 
stress (38). However, the molecular association between UPR and 
macroautophagy is not fully understood.
It has been reported that phosphorylation of eIF2α is very important 
for the induction of autophagy after ER stress. After the phosphory-
lation of eIF2α, ATF4 is activated and this induces the expression of 
ATG12, which is important for the elongation step of macroautopha-
gy (39). In addition, ATF4 increases the regulation of Tribbles homo-
logue 3 (TRB3), which inhibits the Akt/mTORC1 pathway and ensures 
the induction of autophagy. Another ER stress sensor, IRE1, activates 
TRAF2 and ASK1. The activated ASK1 then induce JNK. Depending 
on JNK activation, Bcl2 phosphorylation increases (40). As a result, 
Bcl2 disassociates from Beclin1, resulting in the induction of auto-
phagy (41). The other mechanism to induce autophagy through ER 
stress is carried out by inositol 1, 4, 5-triphosphate receptor (IP3R) 
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that resides in the ER membrane. IP3R can interact with Beclin1. Thus, 
inhibition of IP3R pharmacologically causes its disassociation from 
Beclin1, which induces autophagy (42). Another reason of autoph-
agy induction by ER stress is the release of calcium ions from the ER 
lumen. Three pathways have been identified. The first one includes 
the phosphorylation and activation of AMP-activated protein kinase 
(AMPK) by Ca2+/calmodulin-dependent kinase kinase β (CaCMKKβ). 
Because activated AMPK inhibits the mammalian target of rapamycin 
complex 1 (mTORC1), autophagy is induced. The second pathway de-
pends on the activation of death-associated protein kinase 1 (DAPK) 
as a result of calcium release. After activation, DAPK phosphorylates 
Beclin1 and cause its disassociation from Bcl2. In the third pathway, it 
is believed that autophagy can be induced through the activation of 
protein kinase C theta (PKCθ) (40).
 
4. ER Stress and Diseases
The activated ER stress response has been found several human dis-
eases. It is known that prolonged ER stress and thereby cell death is as-
sociated with some neurodegenerative disorders such as Alzheimer’s 
disease, Parkinson’s disease, and amyotrophic lateral sclerosis (43, 44). 
In addition, it has been shown that there is an association between ER 
stress and some other diseases such as type 2 diabetes (45-47), athero-
sclerosis (48), alcoholic liver disease (49), HBV and HCV infection (50), 
Huntington disease (51), prion disease (52), and cancer (53-55). 
Cancer cells need an increased rate of protein folding and assembly 
in the ER because of their fast growth and proliferation pattern. Can-
cer cells produce hostile microenvironmental conditions, such as hy-
poxia, hypoglycemia, and acidosis, which are known to be triggers of 
ER stress (17). Evidence indicates that the UPR pathway is important 
for cancer cell survival. Several findings suggest that there is an asso-
ciation between ER stress and cancer. One of them is the tumor-spe-
cific microenvironment that causes activation of ER stress. Because of 
hypoxia (which is a general consequence of solid tumors), ATF4 be-
comes activated, resulting in the activation of UPR (56). Thus, in gen-
eral, it can be considered that UPR activation has a positive effect on 
tumor survival under hypoxic conditions. The other is shown by the 
knockdown of GRP78 or CHOP, which results in chemosensitivity. In 
addition, it is known that cancer cells display chronic ER stress mark-
ers (17). For example, increased Grp78 expression has been observed 
in malignant breast cancer and colon adenocarcinoma cell lines and 
in hepatocellular carcinomas (57). This high expression of Grp78 is 
thought to aid the survival of cancer cells and is important for drug 
resistance (58). However, proapoptotic CHOP as an opposite of the 
GRP78 is generally not expressed in tumor tissues because GRP78 
acts to keep CHOP transcription at low levels (59, 60). Furthermore, 
it has been shown that in PERK-deficient cancer cells, the amount of 
angiogenesis is decreased, resulting in a smaller size of the tumor 
(61). Besides, XBP1 overexpression has been shown in different can-
cer types, including breast cancer and hepatocellular carcinomas 
(62). Therefore, these pathways are targeted for chemotherapy of 
different types of cancers (62). In contrast to these studies, a recent 
study has shown that UPR is downregulated in mouse prostate can-
cer models (63). This observation suggests that the role of ER stress in 
cancer is more complex than thought.
5. ER Stress and Pancreatic Cancer
The pancreas has both endocrine and exocrine parts. There are two 
types of tumors in pancreas depending on the affected part of the or-
gan. Tumor formation in the exocrine pancreas is more frequent than 
that in the endocrine pancreas. In addition, the symptoms and cures 
are different. Pancreatic cancer is characterized by rapid invasiveness, 
progression, and profound resistance to treatment. Pancreatic cancer 
is slightly more common in women than in men and the risk increas-
es with age. In addition, family history is an important risk factor (64). 
Pancreatic cancer has a very high rate of mortality because there are 
no effective therapies for this type of tumor at present. Pancreatic 
cancer often has poor prognosis, even when diagnosed early. Detec-
tion of pancreatic cancer in the early stages is very rare, which is a 
major reason why it is a leading cause of cancer-associated death. 
The reason for late detection is that the signs and symptoms may 
not appear until the cancer has reached an advanced stage. At this 
stage, surgical removal of the complete tumorigenic part is not pos-
sible (65).
Pancreatic epithelial cells have high hormone and enzyme secretion 
function. Therefore, it has highly developed ER (66). A previous study 
has shown that ER stress is involved in the induction of apoptosis in 
pancreatic cancer cells by capsaicin, which is a homovanillic acid de-
rivative and used as an analgesic. It has been shown that capsaicin 
increases the expression of GRP78, PERK, eIF2α, ATF4, and GADD153 
in tumor tissues. In addition, its effects on the induction of apoptosis 
and association with ER stress have been shown (65). Another treat-
ment agent, bortezomib (a proteosome inhibitor), induces apoptosis 
in pancreatic cancer cells through ER stress process (67). A previous 
study that used bortezomib showed that there is an increase in the 
expression of CHOP and BIP but inhibition of PERK and phosphorylat-
ed eIF2α (67) and that bortezomib induces ER stress-mediated apop-
tosis in pancreatic cancer cell lines (68). Another study investigating 
the effects of different agents (such as quercetin, anticancer agents, 
and antiapoptotic agent) on pancreatic cancer cell line revealed that 
there is activation of PERK and an increase in the expression of Grp78/
BiP and GADD153/CHOP (69). Therefore, there is a definite associa-
tion between ER stress and pancreatic cancer; however, studies on 
this topic are not enough, necessitating further research in this field.
ER is a very important organelle because of its multifunctional prop-
erties. It is particularly important for tissues that have high protein 
synthesis and secretion potential. Abnormalities in ER function lead 
to ER stress, whose connection with a variety of diseases is already 
known. As a result of ER stress, UPR response is activated, which is 
an evolutionarily conserved homeostasis mechanism. This mecha-
nism is well known, but there are some missing parts that need to 
be elucidated. It should be kept in mind that UPR has dual function 
in cell survival and cell death. There are several studies that target the 
relevant UPR pathway component for treatment of the associated 
disease. Besides some of these studies are hopeful. However, more 
studies are needed, particularly on pancreatic cancer treatment, 
that not only target the UPR pathway but also elucidate the general 
mechanisms. Worldwide, cancer treatment is improving, but pancre-
atic cancer still has a low cure potential with its insidious progress. 
Deeper understanding of the mechanisms and missing points of UPR 
and ER stress and the association with certain types of diseases will 
be important because it may provide novel therapeutic approaches.
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